Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes

Human Gene Therapy

Volumn 9, Issue 1, 1998, Pages 53-62

  Jung, Dirk ^a   Jaeger, Elke ^b   Cayeux, Sophie ^c   Blankenstein, Thomas ^d   Hilmes, Christine ^a   Karbach, Julia ^b   Moebius, Ulrich ^e   Knuth, Alexander ^b   Huber, Christoph ^a   Seliger, Barbara ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KRANKENHAUS NORDWEST   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B7 ANTIGEN; HYBRID PROTEIN; HYGROMYCIN; THYMIDINE KINASE;

ARTICLE; CANCER CELL CULTURE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; KIDNEY CARCINOMA; LYMPHOCYTE ACTIVATION; MARKER GENE; RETROVIRUS;

EID: 17344364609     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.1-53     Document Type: Article

References (8)

1. ALEXANDER, J.P., KUDOH, S., MELSOP, K.A., HAMILTON, T.A., EDINGER, M.G., TUBBS, R.R., SICA, D., TUASON, L., KLEIN, E., BUKOWSKI, R.M., and FINKE, J.H. (1993). T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res. 53, 1380-1387.
2. BAIN, C., MERROUCHE, Y., PUISIEUX, I., DUC, A., COLOMBO, M.P., and FAVROT, M. (1995). B7-1 gene transduction of human renal-cell-carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells. Int. J. Cancer. 67, 769-776.
3. BASKAR, S., GLIMCHER, L., NABAVI, N., JONES, R.T., and OSTRAND-ROSENBERG, S. (1995). Major histocompatibility complex class II + B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 181, 619-629.
4. BERNHARD, H., KARBACH, J., WÖLFEL, T., BUSCH, P., STÖRKEL, S., STÖCKLE, M., WÖFEL, C., SELIGER, B., HUBER, C., MEYER ZUM BÜSCHENFELDE, K.-H., and KNUTH, A. (1994). Cellular immune response to human renal cell carcinomas: definition of a common antigen recognized by HLA-A2 restricted cytotoxic T lymphocytes. Int. J. Cancer. 59, 1-6.
5. BERNHARD, H., MAEURER, M.J., JÄGER, E., WÖLFEL, T., SCHNEIDER, J., KARBACH, J., SELIGER, B., HUBER, C., and KNUTH, A. (1996). Recognition of human renal cell carcinoma and melanoma by HLA-A2 restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-γ. Scand. J. Immunol. 44, 285-292.
6. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
7. YANG, Y., LI, Q., ERTL, H.C., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
8. ZSENGELLER, Z.K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 457-467.